跳至主要内容
临床试验/NCT01251601
NCT01251601撤回不适用

The Effect of Pregnancy on the Pharmacokinetics of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters

University of North Carolina, Chapel Hill0 个研究点开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回

研究概览

简要总结

The purpose of this study is to determine whether pregnancy affects the blood concentrations of raltegravir by comparing the second trimester and third trimester drug concentrations with post partum.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • HIV Infected
  • At least 18 years of age
  • Planning to initiate or currently received raltegravir as part of an antiretroviral regimen with plans to continue at least 8-10 weeks post partum

排除标准

  • Less than 18 years of age
  • Hemoglobin <9 g/dL or Hematocrit <27.3 at screening

研究者

申办方类型
Other
责任方
Sponsor

相似试验

The Effect of Pregnancy on the PK of Isentress®: A... | 临床试验